المؤلفون: Kim, Edward S, Kelly, Karen, Paz-Ares, Luis G, Garrido, Pilar, Jalal, Shadia, Mahadevan, Daruka, Gutierrez, Martin, Provencio, Mariano, Schaefer, Eric, Shaheen, Monte, Johnston, Erica L, Turner, P Kellie, Kambhampati, Siva Rama Prasad, Beckmann, Richard, Hossain, Anwar, John, William J, Goldman, Jonathan W

المصدر: Clinical Cancer Research. 24(22)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Clinical Research, Lung, Clinical Trials and Supportive Activities, Digestive Diseases, Cancer, Lung Cancer, Evaluation of treatments and therapeutic interventions, Development of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 5.1 Pharmaceuticals, Adult, Aged, Aged, 80 and over, Aminopyridines, Antineoplastic Combined Chemotherapy Protocols, Benzimidazoles, Carcinoma, Non-Small-Cell Lung, Drug Administration Schedule, Female, Humans, Lung Neoplasms, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Staging, Treatment Outcome, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/44q4x16z

المؤلفون: Chappell, Jill C., Chiang, Alan Y., Royalty, Jane, Coleman, Hugh, Kulanthaivel, Palaniappan, Turner, P. Kellie

المصدر: Clinical and Translational Science ; volume 16, issue 9, page 1617-1627 ; ISSN 1752-8054 1752-8062

الاتاحة: http://dx.doi.org/10.1111/cts.13573
https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13573

المؤلفون: Toi, Masakazu, Inoue, Kenichi, Masuda, Norikazu, Iwata, Hiroji, Sohn, Joohyuk, Hae Park, In, Im, Seock-Ah, Chen, Shin-Cheh, Enatsu, Sotaro, Turner, P. Kellie, Andre, Valerie A. M., Hardebeck, Molly C., Sakaguchi, Sachi, Goetz, Matthew P., Sledge, George W., Jr.

المساهمون: 임석아, Im, Seock-Ah

مصطلحات موضوعية: INITIAL THERAPY, INHIBITOR, CDK4, abemaciclib, breast cancer, cyclin&, #8208, dependent kinase inhibitor, East Asia, metastatic

Relation: Cancer Science, Vol.112 No.6, pp.2381-2392; 136911; https://hdl.handle.net/10371/177202; 000645940900001; 2-s2.0-85104102846

الاتاحة: https://hdl.handle.net/10371/177202
https://doi.org/10.1111/cas.14877

المؤلفون: Morschhauser, Franck, Bouabdallah, Kamal, Stilgenbauer, Stephan, Thieblemont, Catherine, de Guibert, Sophie, Zettl, Florian, Gelbert, Lawrence M, Turner, P Kellie, Kambhampati, Siva Rama Prasad, Li, Li, Li, Lily Q, Buchanan, Sean, Barriga, Susana, Bear, Melissa M, Wilhelm, Martin, Hess, Georg

المساهمون: Hôpital Claude Huriez Lille, Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Université de Lille-Université de Lille, CHU Bordeaux, Universität Ulm - Ulm University Ulm, Allemagne, Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Ponchaillou, Georg-August-University = Georg-August-Universität Göttingen, LMG PharmaTech, Eli Lilly and Company Indianapolis, Klinikum Nürnberg Nord, Johannes Gutenberg - Universität Mainz = Johannes Gutenberg University (JGU)

المصدر: ISSN: 0390-6078.

مصطلحات موضوعية: Abemaciclib, CDK4 and 6 inhibitor, Mantle cell lymphoma, non-Hodgkin lymphoma, [SDV]Life Sciences [q-bio], [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology

Relation: info:eu-repo/semantics/altIdentifier/pmid/32381571; hal-02635130; https://univ-rennes.hal.science/hal-02635130; https://univ-rennes.hal.science/hal-02635130/document; https://univ-rennes.hal.science/hal-02635130/file/Morschhauser%20et%20al-2020-Clinical%20activity%20of%20abemaciclib%20in%20patients%20with%20relapsed%20or%20refractory%20mantle.pdf; PUBMED: 32381571

الاتاحة: https://univ-rennes.hal.science/hal-02635130
https://univ-rennes.hal.science/hal-02635130/document
https://univ-rennes.hal.science/hal-02635130/file/Morschhauser%20et%20al-2020-Clinical%20activity%20of%20abemaciclib%20in%20patients%20with%20relapsed%20or%20refractory%20mantle.pdf
https://doi.org/10.3324/haematol.2019.224535

المؤلفون: Posada, Maria M., Morse, Bridget L., Turner, P. Kellie, Kulanthaivel, Palaniappan, Hall, Stephen D., Dickinson, Gemma L.

المساهمون: Eli Lilly and Company

المصدر: The Journal of Clinical Pharmacology ; volume 60, issue 7, page 915-930 ; ISSN 0091-2700 1552-4604

الاتاحة: http://dx.doi.org/10.1002/jcph.1584
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcph.1584
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1584
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jcph.1584
https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1584

المؤلفون: Chigutsa, Emmanuel, Kambhampati, Siva Rama Prasad, Karen Sykes, Amanda, Posada, Maria M., van der Walt, Jan‐Stefan, Turner, P. Kellie

المساهمون: Eli Lilly and Company

المصدر: CPT: Pharmacometrics & Systems Pharmacology ; volume 9, issue 9, page 523-533 ; ISSN 2163-8306 2163-8306

الاتاحة: http://dx.doi.org/10.1002/psp4.12544
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpsp4.12544
https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12544
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/psp4.12544
https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12544

المؤلفون: Nicholls, Stephen J., Nissen, Steven E., Fleming, Cynthia, Urva, Shweta, Suico, Jeffrey, Berg, Paul H., Linnebjerg, Helle, Ruotolo, Giacomo, Turner, P. Kellie, Michael, Laura F.

المصدر: JAMA ; volume 330, issue 11, page 1042 ; ISSN 0098-7484

الاتاحة: http://dx.doi.org/10.1001/jama.2023.16503
https://jamanetwork.com/journals/jama/articlepdf/2808864/jama_nicholls_2023_pc_230005_1695054965.13793.pdf

المؤلفون: Chappell, Jill C., Turner, P. Kellie, Pak, Y. Anne, Bacon, James, Chiang, Alan Y., Royalty, Jane, Hall, Stephen D., Kulanthaivel, Palaniappan, Bonventre, Joseph V.

المساهمون: Eli Lilly and Company, National Institutes of Health

المصدر: Clinical Pharmacology & Therapeutics ; volume 105, issue 5, page 1187-1195 ; ISSN 0009-9236 1532-6535

الاتاحة: http://dx.doi.org/10.1002/cpt.1296
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcpt.1296
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1296
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/cpt.1296
https://ascpt.onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1296

المؤلفون: Tate, Sonya C., Sykes, Amanda K., Kulanthaivel, Palaniappan, Chan, Edward M., Turner, P. Kellie, Cronier, Damien M.

المصدر: Clinical Pharmacokinetics ; volume 57, issue 3, page 335-344 ; ISSN 0312-5963 1179-1926

الاتاحة: http://dx.doi.org/10.1007/s40262-017-0559-8
https://link.springer.com/article/10.1007/s40262-017-0559-8/fulltext.html
https://link.springer.com/content/pdf/10.1007/s40262-017-0559-8.pdf

المؤلفون: Kim, Edward S., Kelly, Karen, Paz-Ares, Luis G., Garrido, Pilar, Jalal, Shadia, Mahadevan, Daruka, Gutierrez, Martin, Provencio, Mariano, Schaefer, Eric, Shaheen, Monte, Johnston, Erica L., Turner, P. Kellie, Kambhampati, Siva Rama Prasad, Beckmann, Richard, Hossain, Anwar, John, William J., Goldman, Jonathan W.

المساهمون: Medicine, School of Medicine

المصدر: Author

مصطلحات موضوعية: lung cancer, Abemaciclib, metastatic NSCLC

وصف الملف: application/pdf

Relation: Clinical Cancer Research; Kim, E. S., Kelly, K., Paz-Ares, L. G., Garrido, P., Jalal, S., Mahadevan, D., … Goldman, J. W. (2018). Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study. Clinical Cancer Research, 24(22), 5543–5551. https://doi.org/10.1158/1078-0432.CCR-18-0651; https://hdl.handle.net/1805/20375

الاتاحة: https://hdl.handle.net/1805/20375

المؤلفون: Fujiwara, Yutaka, Tamura, Kenji, Kondo, Shunsuke, Tanabe, Yuko, Iwasa, Satoru, Shimomura, Akihiko, Kitano, Shigehisa, Ogasawara, Ken, Turner, P. Kellie, Mori, Joji, Asou, Hiroya, Chan, Edward Michael, Yamamoto, Noboru

المساهمون: Eli Lilly Japan K.K.

المصدر: Cancer Chemotherapy and Pharmacology ; volume 78, issue 2, page 281-288 ; ISSN 0344-5704 1432-0843

الاتاحة: http://dx.doi.org/10.1007/s00280-016-3085-8
http://link.springer.com/content/pdf/10.1007/s00280-016-3085-8.pdf
http://link.springer.com/article/10.1007/s00280-016-3085-8/fulltext.html
http://link.springer.com/content/pdf/10.1007/s00280-016-3085-8

المؤلفون: Chappell, Jill C., Turner, P. Kellie, Pak, Y. Anne, Bacon, James, Chiang, Alan Y., Hall, Stephen D., Kulanthaivel, Palaniappan, Royalty, Jane, Bonventre, Joseph V.

المصدر: Clinical Pharmacology & Therapeutics; May2019, Vol. 105 Issue 5, p1187-1195, 9p

مصطلحات موضوعية: GLOMERULAR filtration rate, CYCLIN-dependent kinases, BREAST cancer treatment, METFORMIN, CREATININE

المؤلفون: Turner, P. Kellie, Veal, Gareth J.

المصدر: Pharmacogenetics: Making cancer treatment safer and more effective ; page 101-113 ; ISBN 9789048186174 9789048186181

الاتاحة: http://dx.doi.org/10.1007/978-90-481-8618-1_7
http://link.springer.com/content/pdf/10.1007/978-90-481-8618-1_7

المؤلفون: Iacono, Lisa C., Turner, P. Kellie, Stewart, Clinton F.

المصدر: Handbook of Anticancer Pharmacokinetics and Pharmacodynamics ; page 395-419 ; ISBN 9781475753455 9781592597345

الاتاحة: http://dx.doi.org/10.1007/978-1-59259-734-5_24
http://link.springer.com/content/pdf/10.1007/978-1-59259-734-5_24

المؤلفون: Hamid, Omid, Ilaria, Robert, Garbe, Claus, Wolter, Pascal, Maio, Michele, Hutson, Thomas E., Arance, Ana, Lorigan, Paul, Lee, Jeeyun, Hauschild, Axel, Mohr, Peter, Hahka-Kemppinen, Marjo, Kaiser, Christopher, Turner, P. Kellie, Conti, Ilaria, Grob, Jean Jacques

المصدر: Hamid , O , Ilaria , R , Garbe , C , Wolter , P , Maio , M , Hutson , T E , Arance , A , Lorigan , P , Lee , J , Hauschild , A , Mohr , P , Hahka-Kemppinen , M , Kaiser , C , Turner , P K , Conti , I & Grob , J J 2014 , ' A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma ' , Cancer , vol. 120 , no. 13 , pp. 2016-2024 ....

مصطلحات موضوعية: clinical trial, LY573636, melanoma, paclitaxel, phase 3 chemotherapy, tasisulam

الاتاحة: https://research.manchester.ac.uk/en/publications/fbcf4a7d-f6a3-48a0-9001-1be533f6d78d
https://doi.org/10.1002/cncr.28635
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142

المؤلفون: Jotte, Robert M., Von Hoff, Daniel D., Braiteh, Fadi, Becerra, Carlos R., Richards, Donald A., Smith, David A., Garbo, Lawrence, Stephenson, Joe, Conkling, Paul R., Robert-Vizcarrondo, Francisco, Chen, Jian, Turner, P. Kellie, Chow, Kay Hoong, Tai, D. Fritz, Ilaria, Robert

المصدر: Investigational New Drugs ; volume 33, issue 1, page 148-158 ; ISSN 0167-6997 1573-0646

الاتاحة: http://dx.doi.org/10.1007/s10637-014-0160-z
https://link.springer.com/content/pdf/10.1007/s10637-014-0160-z.pdf
https://link.springer.com/article/10.1007/s10637-014-0160-z/fulltext.html
http://link.springer.com/content/pdf/10.1007/s10637-014-0160-z

المؤلفون: Tate, Sonya C., Sykes, Amanda K., Kulanthaivel, Palaniappan, Chan, Edward M., Turner, P. Kellie, Cronier, Damien M.

المصدر: Clinical Pharmacokinetics; Mar2018, Vol. 57 Issue 3, p335-344, 10p

مصطلحات موضوعية: PHARMACOKINETICS, CHEMICAL kinetics, CLINICAL trials, CANCER treatment, CANCER patients

المؤلفون: Turner, P. Kellie, Hall, Stephen D., Chapman, Sonya C., Rehmel, Jessica L., Royalty, Jane E., Guo, Yingying, Kulanthaivel, Palaniappan

المصدر: Drug Metabolism and Disposition; 2020, Vol. 48 Issue: 9 p796-803, 8p

المؤلفون: Houghton, Janet A., Petak, Istvan, Tillman, David M., Douglas, Leslie, Schwartzberg, Lee, Billups, Catherine A., Panetta, John C., Stewart, Clinton F., Turner, P. Kellie

المصدر: Cancer Chemotherapy and Pharmacology ; volume 53, issue 3, page 253-260 ; ISSN 0344-5704 1432-0843

الاتاحة: http://dx.doi.org/10.1007/s00280-003-0723-8
http://link.springer.com/content/pdf/10.1007/s00280-003-0723-8.pdf
http://link.springer.com/article/10.1007/s00280-003-0723-8/fulltext.html
http://link.springer.com/content/pdf/10.1007/s00280-003-0723-8

المؤلفون: Turner, P. Kellie¹, Iacono, Lisa C.¹, Panetta, John C.^1,2, Santana, Victor M.^3,4, Daw, Najat C.^3,4, Gajjar, Amar^3,4, Stewart, Clinton F.^1,4 clinton.stewart@stjude.org

المصدر: Cancer Chemotherapy & Pharmacology. Apr2006, Vol. 57 Issue 4, p475-482. 8p.

مصطلحات موضوعية: *LACTONES, *ORGANIC cyclic compounds, *PHARMACOKINETICS, *ANTINEOPLASTIC agents, *CANCER chemotherapy, *CHILDHOOD cancer